Update on the approach to smoking in patients with respiratory diseases
Carregando...
Data
2019-06-27
Autores
Sales, Maria Penha Uchoa
Araújo, Alberto José de
Chatkin, José Miguel
Godoy, Irma de [UNESP]
Pereira, Luiz Fernando Ferreira
Castellano, Maria Vera Cruz de Oliveira
Tanni, Suzana Erico [UNESP]
Almeida, Adriana Ávila de
Chatkin, Gustavo
Silva, Luiz Carlos Côrrea da
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Smoking is the leading cause of respiratory disease (RD). The harmful effects of smoking on the respiratory system begin in utero and influence immune responses throughout childhood and adult life. In comparison with healthy smokers, smokers with RD have peculiarities that can impede smoking cessation, such as a higher level of nicotine dependence; nicotine withdrawal; higher levels of exhaled carbon monoxide; low motivation and low self-efficacy; greater concern about weight gain; and a high prevalence of anxiety and depression. In addition, they require more intensive, prolonged treatment. It is always necessary to educate such individuals about the fact that quitting smoking is the only measure that will reduce the progression of RD and improve their quality of life, regardless of the duration and severity of the disease. Physicians should always offer smoking cessation treatment. Outpatient or inpatient smoking cessation treatment should be multidisciplinary, based on behavioral interventions and pharmacotherapy. It will thus be more effective and cost-effective, doubling the chances of success.
Descrição
Palavras-chave
Como citar
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, v. 45, n. 3, p. e20180314-, 2019.